-The Hindu The efforts to win the war against tuberculosis using an efficacious vaccine candidate (MVA85A) in infants aged 4-6 months have returned a disappointing verdict despite showing great promise in pre-clinical trials. Though it fulfilled the primary objective of safety and despite inducing modest immune responses, the efficacy of the vaccine was just 17.3 per cent, and hence considered insufficient to protect the infants against TB, notes a paper published...

-AFP Delegations from some 140 countries agreed on Saturday to adopt a ground-breaking treaty limiting the use and emission of health-hazardous mercury, the U.N. said, though environmental activists lamented it did not go far enough. The world’s first legally binding treaty on mercury, reached after a week of thorny talks, will aim to reduce global emission levels of the toxic heavy metal, also known as quicksilver, which poses risks to human health...

-The Hindu The large sums of money spent in the eradication of the disease is an investment in the economic development of the country In the 1980s, only three decades ago, 200,000 to 400,000 children, all under 5 years, were afflicted with polio paralysis annually in India. That was a daily average of 500 to 1000 cases. By the age of six, eight among 1,000 children already had polio paralysis; two would...

-The Hindu In a major boost to the country’s private vaccine manufacturing pharmaceutical companies, the World Health Organisation (WHO) has said that India’s national regulatory authority — Central Drugs Standard Control Organisation (CDSCO) — and its affiliated institutions meet the prescribed international standards. India is a major vaccine producer with 12 major vaccine manufacturing facilities. These Vaccines are used for the national and international market, reaching nearly 150 countries. Every second child...

-The Telegraph A children’s vaccine against a stomach infection has triggered controversy with some doctors claiming there is not enough data to show it is effective in India and accusing a leading drug company of using a misleading advertisement to promote the vaccine. GlaxoSmithKline Pharmaceuticals (GSK) has stopped the advertisement for the vaccine intended to protect children from potentially life-threatening rotavirus infections after the advertising industry’s self-regulating body upheld a doctor’s complaint...